Use of infusions of FIBRINOLYTIC AGENTS to destroy or dissolve thrombi in blood vessels or bypass grafts.
More specific conditions that are subtypes of Thrombolytic Therapy in the MeSH hierarchy.
Phase 4 trials (3)